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 Abstract 
 Objective: Placenta increta or percreta is an uncommon 
pathology, sometimes associated with high maternal morbid-
ity. Its prevalence increases proportionally to the number of 
cesarean sections. This study analyzed the changes of our 
management strategy to devise treatment guidelines for this 
uncommon disorder. 
 Materials and methodology: Between 2005 and 2011, 10 
cases of placenta increta or percreta were managed at our uni-
versity hospital maternity department. 
 Results: Among the 10 cases, seven were diagnosed prena-
tally. Two patients were diagnosed early, at 14 and 17 weeks 
of gestational age, and their pregnancies were terminated. 
Five had hysterectomies during the intrapartum period, 
and despite attempted conservative treatment for the two 
others, hysterectomy proved necessary 2 months postpartum 
because of intrauterine infections. Seven of the 10 women 
had hysterectomies. 
 Conclusion: Prenatal diagnosis of placenta increta or per-
creta is essential to plan the delivery in a competent tertiary 
care center. The decision to perform a cesarean hysterectomy 
or leave the placenta  in situ for spontaneous delivery is based 
on the extent of infi ltration, the patient ’ s hemodynamic status, 
and her desire to remain fertile. The high-risk of infection and 
severe hemorrhage must not be overlooked should conserva-
tive treatment be chosen. This situation requires prolonged 
close monitoring. 
 Keywords:  Embolization;  hysterectomy;  placenta increta; 
 placenta percreta;  postpartum hemorrhage;  ultrasound. 
 Introduction 
 There are varying degrees of abnormal trophoblast infi ltra-
tion into the implantation site, namely, in increasing order of 
severity, placenta accreta, placenta increta, and placenta per-
creta. These implantation abnormalities affect 1 in 1000 – 2500 
deliveries  [16, 22] . 
 Placenta percreta is trophoblast invasion of the myome-
trium to the uterine perimetrium (tunica serosa uteri) and, in 
certain cases, can exceed this limit and infi ltrate into the sur-
rounding organs, e.g., the bladder or bowel. Concurrent with 
the increasing numbers of scarred uteri, the placenta percreta 
prevalence has clearly risen over these past few years  [6] . 
It is often associated with placenta previa. Clarke et al.  [2] 
showed that, when placenta previa was present, the risk of 
placenta accreta increased from 24 % for a patient with one 
previous cesarean delivery to 67 % for a patient with three 
or more cesarean deliveries. Specifi cally, placenta percreta is 
associated with high maternal morbidity and as much as 7 % 
maternal mortality  [17] . 
 Prenatal diagnosis followed by optimal management at an 
appropriate tertiary care center is essential to limit the devas-
tating maternal consequences and to decide the most appro-
priate surgical strategy: conservative management with the 
placenta left  in situ after cesarean delivery, or hysterectomy, 
possibly associated with extensive pelvic surgery. The former 
therapeutic approach exposes the woman to prolonged risks 
of hemorrhage and endometrial infection or sepsis, whereas 
the latter may prove extremely diffi cult to achieve when per-
creta placentation is associated with parametrial invasion. 
 The purpose of this study was to retrospectively analyze 
the last 10 patients diagnosed with placenta increta or per-
creta and treated in our university hospital maternity depart-
ment and to evaluate their outcomes in comparison to those 
in the literature. Based on our own experience and a literature 
review, several clinical recommendations are proposed. 
 Patients and methods 
 Our tertiary care maternity unit performs 2300 deliveries annually 
and is the referral center for high-risk pregnancies from a network of 
maternity hospitals performing 15,000 deliveries a year. 
 This retrospective study included all 10 cases of placenta increta 
and percreta treated between June 2005 and June 2011. Clinical infor-
mation was obtained from the written delivery reports and databases 
of the Pathology and Radiology Departments. Data from intrahos-
pital management and examinations performed in referring centers 
were compared and analyzed on a case-by-case basis. 
 Placenta increta and percreta were suspected based on ultrasono-
graphy, followed by magnetic resonance imaging (MRI), verifi ed 
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during cesarean delivery, and confi rmed by histopathological exami-
nation of surgical hysterectomy specimens. 
 Results 
 The demographic and clinical characteristics of the 10 women 
are reported in Table  1 . All of them presented risk factors for 
abnormal placental implantation: previous cesarean deliv-
ery, curettage or other uterine surgery, or placenta accreta. 
Notably, for seven women, six of whom had with more than 
one cesarean delivery, placenta percreta was diagnosed pre-
natally. Placental insertion was anterior and previa in seven 
of 10 cases. Patient 6 ’ s placenta invaded the fundus of the 
uterus, probably linked to her postpartum curettage after a 
previous vaginal birth. The infi ltration of the surrounding tis-
sues and/or vesicouterine fold was confi rmed intraoperatively 
for patients 1, 2, 4, and 5. Their placentas were left  in situ , 
after their fetuses had been extracted through a vertical fundal 
hysterotomy. Patient 10 had placenta percreta infi ltrating the 
posterior and fundal walls of the uterus, which had been sus-
pected preoperatively and was confi rmed during laparotomy, 
when infi ltration of the mesocolon was also diagnosed. After 
fetal delivery, the uterus with the placenta  in situ and 30 cm of 
the sigmoid colon were resected  en bloc (Figure  1 ). 
 In total, seven hysterectomies were performed: four dur-
ing cesarean deliveries (two because of massive intraopera-
tive bleeding and two were elective), one several hours after 
massive hemorrhaging, and two were done 2 months after 
cesarean deliveries because of intrauterine infection and pel-
vic abscess, respectively. 
 Patients 2 – 5, 8, and 9 received blood transfusions (mean, 
7 units; range, 2 – 13 units). Patients 3, 8, and 9 experienced 
massive hemorrhage when manual placental removal was 
attempted. The details of therapeutic management are given 
in Table  2 , with cases listed in chronological order. 
A B
 Figure 1  Case 10. 
 (A) Posterior and fundal placenta percreta invading the uterine serosa and adherent to the sigmoid colon (white arrow). This photo was taken 
after fetal delivery. The black arrow indicates placenta percreta infi ltration of the mesocolon. (B) Surgical specimen showing the  en bloc resec-
tion of the uterus and 30 cm of sigmoid colon. The white arrow points to one end of the sigmoid colon. 
 Table 1  Characteristics of the 10 women with placenta percreta. 
Characteristic Valuea
Age 30.0 (24 – 37)
Gravidity   4.2 (2 – 7)
Parity   2.4 (1 – 5)
Risk factors 10/10
  Previous manual placental delivery   2/10
  Previous curettage   4/10
  At least one previous cesarean   7/10
Prenatal diagnosis   7/10
Complementary MRI   7/10
Parametrial, bladder, or bowel invasion   6/10
 
aValues are expressed as mean (range) or number. 
 Discussion 
 The real prevalence of placenta accreta cannot be determined 
with certainty. Indeed, simple placenta accreta is most often 
resolved by manual delivery for incomplete separation. No 
histopathological confi rmation can be made in these situa-
tions, for which obstetrical management is standard and well 
established. In their report on 310 cases of placenta accreta, 
Gielchinsky et al.  [4] also cited the diffi culty of making this 
diagnosis. Therefore, we analyzed only our case series with 
placenta increta or percreta because the clinical signs and pre-
natal diagnosis are more obvious when the ultrasonographer 
pays particular attention to the implantation site. Placenta 
increta or percreta is less common than placenta accreta but is 
responsible for greater morbidity and even maternal and fetal 
mortality  [17] . 
 The most troubling ultrasound signs of placenta percreta 
are the absence of retroplacental myometrium, intraplacental 
basal hypoechogenic lacunae, and high-fl ow, low-resistance 
vascularization (color and pulsed Doppler)  [18] . All these 
!"#$%&'('#()#$(*)(+(,-./0"1.'0(20(3.0%0(4,-./0"1.'0(20(3.0%05
6$'&0-'.78'02(+(9:;<9=<9<;;=
>#?-@#82(>8'0(+(ABCB9;(;DEF(GH
Chantraine et al., Placenta in- and percreta: a case series  267
 Ta
bl
e 
2   
   M
an
ag
em
en
t o
f t
he
 1
0 
ca
se
s o
f p
la
ce
nt
a 
pe
rc
re
ta
.  
Ca
se
D
ia
gn
o
sis
 
(w
ee
ks
 o
f g
es
ta
tio
n
)
Ce
sa
re
a
n
 
(w
ee
ks
 o
f g
es
ta
tio
n
)
Em
bo
liz
at
io
n
M
TX
H
ys
te
re
ct
o
m
y
In
fe
ct
io
n
Tr
a
n
sf
u
sio
n
O
u
tc
om
es
  
 1
17
TO
P,
 
Pi
S
Ye
s
Ye
s
N
o
N
o
N
o
N
o
rm
al
 u
te
ru
s 
12
 m
on
th
s 
la
te
r
  
 2
14
TO
P,
 
Pi
S
Ye
s
Ye
s
N
o
N
o
2 
un
its
N
o
rm
al
 u
te
ru
s 
8 
m
on
th
s 
la
te
r
  
 3
34
37
Ye
s
N
o
Ye
s,
 
in
tr
a-
o
p
N
o
11
 u
n
its
Pl
ac
en
ta
l r
em
o
v
al
 
at
te
m
pt
ed
,
 
m
as
siv
e 
he
m
o
rr
ha
gi
n
g
  
 4
34
36
,
 
Pi
S
Ye
s
Ye
s
Ye
s,
 
2 
m
o
n
th
s 
la
te
r
Ye
s
6 
u
n
its
Su
pe
rin
fe
ct
io
n
  
 5
19
31
,
 
Pi
S
Ye
s
Ye
s
Ye
s,
 
2 
m
on
th
s 
la
te
r
Ye
s
2 
un
its
Pe
lv
ic
 a
bs
ce
ss
  
 6
In
tr
a-
o
p
29
N
o
N
o
N
o
N
o
N
o
El
ec
tiv
e 
re
se
ct
io
n
 
o
f t
he
 
sm
al
l p
er
cr
et
a 
zo
n
e
  
 7
36
36
N
o
N
o
Ye
s,
 
pl
a
n
n
ed
 
in
tr
a-
o
p
N
o
N
o
Fa
v
o
ra
bl
e
  
 8
In
tr
a-
o
p
36
Ye
s
N
o
Ye
s
N
o
13
 
u
n
its
Pl
ac
en
ta
l r
em
o
v
al
 
w
as
 
at
te
m
pt
ed
,
 
m
as
siv
e 
he
m
o
rr
ha
gi
n
g
  
 9
In
tr
a-
o
p
38
N
o
N
o
Ye
s
N
o
8 
u
n
its
Pl
ac
en
ta
l r
em
o
v
al
 
w
as
 
at
te
m
pt
ed
,
 
m
as
siv
e 
he
m
o
rr
ha
gi
n
g
10
30
38
N
o
N
o
Ye
s,
 
pl
a
n
n
ed
 in
tr
a-
o
p
N
o
N
o
Pa
rt
ia
l b
o
w
el
 re
se
ct
io
n
   TO
P  =
  te
rm
in
at
io
n 
of
 p
re
gn
an
cy
,
 
Pi
S  =
  pl
ac
en
ta
 le
ft 
 in
 si
tu
 ,
 
in
tra
-o
p  =
  du
rin
g 
ce
sa
re
an
 d
el
iv
er
y.   
signs were observed in the seven patients with prenatal diag-
noses (Figures  2 and  3 ). In the context of previous cesarean 
delivery and previa, anterior placentation, those three ultra-
sound signs are actively sought, which might account for the 
high percentage of prenatal diagnoses  [13] . 
 For patients diagnosed during prenatal ultrasonography, 
complementary MRI (Figure 2) was carried out to evaluate 
the lateral extension and depth penetration of the placenta. In 
our opinion, correspondence between the fi ndings of the two 
imaging techniques is essential to choose between the two 
possible therapeutic approaches: cesarean delivery combined 
with hysterectomy or cesarean delivery with the placenta 
left  in situ . This approach facilitates planning the delivery, 
especially in terms of selecting the sites for the cutaneous and 
uterine incisions. 
 The diagnoses of placenta percreta in patients 1 and 2 were 
suspected early, at 17 and 14 weeks of gestation, respectively, 
based on ultrasound fi ndings and MRI. After methotrexate 
(MTX) injection (Teva Pharma, Wilrijk, Belgium) and bilateral 
uterine artery embolization, their fetuses were extracted through 
fundal hysterotomy at 20 and 18 weeks of gestation, respectively. 
Their placenta percreta diagnoses were defi nitively confi rmed 
during surgery, and each patient ’ s placenta was left  in situ . In 
addition to placenta percreta, patient 1 also had anhydramnios 
due to the premature rupture of the amniotic sac. Patient 2 ’ s 
request for termination of pregnancy was accepted by the Ethics 
Committee, in light of the extensive placental infi ltration, which 
was likely to deteriorate further with advancing pregnancy. 
Notably, several cases of uterine rupture and massive hemor-
rhaging have been reported for placenta percreta diagnosed at 
the beginning of the second trimester  [3, 12, 14] . 
 It could be hypothesized that placenta increta or percreta is 
the continuation of untreated cesarean scar pregnancy (CSP), 
but it must be kept in mind that different CSP types exist 
 [1, 23] . First, real CSP, with deep implantation into the scar 
defect, is at high-risk of spontaneous uterine rupture. Second, 
when the implantation is  “ on ” or close to a previous cesarean 
section scar, the pregnancy may progress to a viable birth by 
taking the risk of life-threatening hemorrhage due to placenta 
accreta, increta, or percreta. In our opinion, placenta percreta 
in patients 1 and 2 could be attributed to that latter CSP type. 
Because our management of those cases started at 16 and 17 
weeks (second trimester), we prefer the term  “ placenta per-
creta, ” rather than CSP. 
 Four patients underwent cystoscopy, during which absence 
of infi ltration of the bladder mucosa could be ascertained. 
Thus, this semi-invasive examination failed to provide addi-
tional information. In their review of 54 cases of placenta 
percreta with bladder infi ltration diagnosed with ultrasound 
and MRI, Washecka and Behling  [25] reported the failure of 
cystoscopy to prenatally detect bladder mucosa infi ltration. 
In response to those observations, our department no longer 
orders cystoscopy for the diagnostic workup of a patient with 
deep placental invasion into the anterior uterine wall and 
bladder except when macroscopic hematuria is present. 
 Our clinical approach involves planning deliveries of 
placenta percreta at  ∼ 36 weeks ’ gestational age to prevent 
maternal morbidity due to the spontaneous onset of labor 
!"#$%&'('#()#$(*)(+(,-./0"1.'0(20(3.0%0(4,-./0"1.'0(20(3.0%05
6$'&0-'.78'02(+(9:;<9=<9<;;=
>#?-@#82(>8'0(+(ABCB9;(;DEF(GH
268  Chantraine et al., Placenta in- and percreta: a case series
invasion of the bladder wall. Cesarean hysterectomy would 
have been diffi cult technically in the absence of a dissection 
plane and carried a high-risk for the woman. These patients 
also wanted to retain fertility. Several publications described 
the possibility of deferred spontaneous vaginal delivery or 
resorption of the placenta left  in situ  [7, 11, 17] . However, for 
our four patients, no spontaneous placental delivery occurred. 
Total resorption was associated with mild prolonged metror-
rhagia, lasting 12 and 18 months, respectively, for patients 1 
and 2. Patients 4 and 5 developed infections following cesar-
ean delivery, necessitating hysterectomies 2 months later, 
which were subjectively more easily performed than at the 
time of delivery (Figure 4). This risk of infection associated 
with the placenta  in situ is well documented in the literature 
 [5, 10] . 
 Patients 7 and 10 underwent planned cesarean hysterectomy 
because the placenta had not penetrated beyond the perime-
trium (case 7) and cleavage planes for a hysterectomy were 
maintained (both cases). These patients no longer wanted to 
remain fertile and requested one-step surgery, if possible. 
 Forced manual removal of a deeply infi ltrating placenta 
must be avoided to prevent uncontrolled massive hemor-
rhaging, as what occurred in patients 3, 8, and 9. All three 
required multiple blood transfusions (8 – 13 units) and, fi nally, 
hysterectomy. 
 The uterine arteries of patients 1, 2, 4, and 5 were pro-
phylactically embolized just after cesarean delivery to pre-
vent major and unpredictable postpartum bleeding (Figure 4). 
Such systematic preventive embolization without bleeding 
has to be considered carefully. Indeed, for patients 2, 4, and 5, 
it did not prevent major hemorrhaging or the need for second 
embolizations. This failure might be the consequence of the 
extensive lacunae in the myometrium  [19] with high blood 
fl ow, rendering 500- µ m polyvinyl alcohol particles useless. 
Such prophylaxis is no longer performed systematically in 
our department. However, therapeutic embolization remains 
A B
Figure 2 Case 2.
(A) Transvaginal ultrasound showing the anterior and previa placenta percreta exhibiting the following ultrasonographic signs of abnormal 
placenta infi ltration: thinning of the myometrium (virtually absent here), placenta lacunae, and turbulent blood fl ow. (B) MRI (T2-weighted 
sagittal view) showing placenta percreta and previa implanted in the lower anterior wall of the uterus (fetus in situ).
Figure 3 Case 5.
Transvaginal ultrasound showing anterior low-lying placenta per-
creta. The pulsed Doppler shows the high-volume, low-resistance 
blood fl ow.
and delivery. An unscheduled emergency delivery in such 
cases would also markedly increase neonatal risks and mor-
bidity. This strategy is supported by the fi ndings of Warshak 
et al.  [24] , who showed less maternal blood loss but increased 
risk of prematurity, admission to neonatology units, and pro-
longed hospital stays when delivery was planned at 34 – 35 
weeks ’ gestation. Furthermore, O ’ Brien et al.  [17] showed 
that, beyond 36 weeks of gestation, the risk of spontaneous 
bleeding and emergency delivery increased. The optimal time 
of delivery depends on several factors, e.g., placental location, 
cervical length, bleeding episodes, history of preterm deliv-
ery. Individual planning and management is recommended to 
determine the optimal week of delivery for every patient. 
 In our series, after fetal extraction, the placenta was left 
 in situ in four women. This strategy was chosen because of the 
diffuse infi ltration observed, with parametrial involvement and 
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Figure 4 Case 4.
Hysterectomy specimen obtained 2 months after fetal delivery with 
placenta left in situ (indication for hysterectomy: endometrial and 
pelvic infection). Inset: cross-section shows the deep placental infi l-
tration and the persistent presence of uterine artery embolization par-
ticles (white arrowhead), administered immediately after delivery, 
that were unable to adequately fi ll the enlarged vascular lacunae and 
stop the hemorrhaging.
indicated to manage severe hemorrhaging in other obstetrical 
circumstances, e.g., uterine atony or birth canal lacerations. 
 MTX was prescribed as adjuvant therapy to accelerate pla-
cental involution for the four patients whose placentas were 
left  in situ . The doses to be administered are not standardized 
 [7, 9, 18] , and no studies have yet elucidated the risks or ben-
efi ts of this treatment  [18] . Dramatic complications, includ-
ing maternal death, were reported after injecting MTX into 
the umbilical cord  [20] . Among our four patients treated with 
MTX, two developed infectious complications, which might 
be attributable to the immunosuppressive action of MTX. In 
light of these results, our patients with placenta percreta left 
 in situ are no longer given MTX. Progressive regression of 
active trophoblast is monitored by measuring plasma human 
chorionic gonadotropin levels at weekly intervals, biological 
markers of infl ammation, and physical examination. 
 The choice between radical cesarean hysterectomy or the 
more conservative placenta  in situ therapeutic strategy for 
placenta percreta must be made based on the extent of inva-
sion of the parametrium or adjacent organs (bladder and/or 
bowel). If placental trophoblast does not penetrate beyond the 
perimetrium, which sometimes can only be defi nitively deter-
mined intraoperatively, cesarean hysterectomy without pla-
cental removal seems to be the best solution offering the least 
maternal morbidity. If, however, the placenta has infi ltrated 
the perimetrium and surrounding tissues, avoiding placental 
extraction is recommended. The risk of massive hemorrhag-
ing during forced delivery or hysterectomy without classical 
anatomical reference points is very high. Severe placenta per-
creta with invasion of adjacent organs or parametrium remains 
a very dangerous situation for patients, given its associated 
non-negligible morbidity and even mortality  [17, 20] . In such 
instances, delayed hysterectomy can be performed 4 – 6 weeks 
after cesarean delivery. This lag time allows the periuterine 
vascularization to recede and prevents late onset massive 
hemorrhaging or severe infection. 
 Prenatal diagnosis is of course imperative. Based on our 
experience and the literature, it should be possible, especially 
for placenta increta or percreta  [8, 15, 21] . The placental 
implantation site must be explored carefully, especially when 
the placental insertion is anterior and previa and the patient 
has undergone a previous cesarean delivery. If an implanta-
tion abnormality is suspected, the patient must be referred to 
an experienced team to confi rm the diagnosis. Delivery must 
then be planned in an institution that can manage the serious 
complications of this pathology. Postpartum hemorrhage may 
occur early or late and can be unexpected, sudden, and severe. 
Infection of the placenta left  in situ , with its possible progres-
sion to infectious toxic shock and hemorrhage, is another major 
issue to be considered and that requires close monitoring. 
 During the 5 years that these placenta increta and percreta 
patients were managed in our department, we instigated the 
following fi ve changes. Active systemic screening for implan-
tation anomalies during routine prenatal ultrasonography has 
become standard practice and is done thoroughly. When pos-
sible, elective cesarean hysterectomy at 36 – 37 weeks of ges-
tational age is preferred to prevent the severe complications 
associated with postpartum placenta  in situ . The uterine arter-
ies are embolized only when postoperative bleeding occurs. 
MTX is no longer given systematically, as it appears to facili-
tate infectious complications. A multidisciplinary team has 
been established to ensure the management of placenta increta 
and percreta according to standardized guidelines. 
 Conclusion 
 The frequency of placenta increta and percreta is increasing in 
direct relationship to the higher number of cesarean deliveries 
and other types of uterine surgery. Prenatal diagnosis is pos-
sible but requires thorough examination by an experienced 
ultrasonographer, who actively looks for this pathology in 
a patient with an anterior low-lying or previa placenta and 
a history of cesarean delivery or postpartum curettage. This 
prenatal detection should provide accurate information. The 
patient can then be fully informed of her therapeutic options 
and their potential consequences and be optimally prepared 
for delivery by an experienced team. Prenatal diagnosis does 
not necessarily avoid hysterectomy but can ensure reduction 
of maternal risks. 
 A decision between radical and conservative strategies 
for placenta increta and percreta must be made based on the 
degree of placental infi ltration (whether it goes beyond the 
perimetrium and into adjacent organs) and other variables: the 
patient ’ s hemodynamic status and her desire to remain fertile. 
In our opinion, cesarean hysterectomy when the perimetrium 
is intact remains the best therapeutic option to treat placenta 
increta and percreta. If, however, placental invasion largely 
exceeds the perimetrium and/or the patient wishes to remain 
fertile, management of the placenta  in situ is indicated, with 
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full knowledge of the risks of major hemorrhaging and severe 
infection. 
 The benefi ts of prophylactic embolization of the uterine 
arteries and adjuvant MTX administration for placenta  in situ 
are not clear and remain controversial. 
 Multidisciplinary management (obstetrics, surgery, inter-
ventional radiology, anesthesia, etc.) in a referral center is 
indispensable for a favorable outcome. 
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